Aristo Bio-Tech IPO vs Chaman Metallics IPO

Comparison between Aristo Bio-Tech IPO and Chaman Metallics IPO.

IPO Details

Aristo Bio-Tech IPO is a SME Fixed Price IPO proposed to list at NSE SME while Chaman Metallics IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Aristo Bio-Tech IPO is up to ₹12.40 Cr whereas the issue size of the Chaman Metallics IPO is up to ₹22.98 Cr. The final issue price of Aristo Bio-Tech IPO is ₹72.00 per share and of Chaman Metallics IPO is ₹38.00 per share.

 Aristo Bio-Tech IPOChaman Metallics IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹72.00 per share₹38.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1600 shares3000 shares
Fresh Issue Size17,21,600 shares60,48,000 shares
Fresh Issue Size (Amount)up to ₹12.40 Crup to ₹22.98 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total17,21,600 shares60,48,000 shares
Issue Size Total (Amount)up to ₹12.40 Crup to ₹22.98 Cr

IPO Timetable

Aristo Bio-Tech IPO opens on Jan 16, 2023, while Chaman Metallics IPO opens on Jan 04, 2023. The closing date of Aristo Bio-Tech IPO and Chaman Metallics IPO is Jan 19, 2023, and Jan 06, 2023, respectively.

 Aristo Bio-Tech IPOChaman Metallics IPO
Issue OpenJan 16, 2023Jan 04, 2023
Issue CloseJan 19, 2023Jan 06, 2023
Basis Of Allotment (Tentative)Jan 24, 2023Jan 11, 2023
Initiation of Refunds (Tentative)Jan 25, 2023Jan 12, 2023
Credit of Share (Tentative)Jan 27, 2023Jan 13, 2023
Listing date (Tentative)Jan 30, 2023Jan 16, 2023

Financials & KPIs

Aristo Bio-Tech IPO P/E ratio is 9.46, as compared to Chaman Metallics IPO P/E ratio of 6.73.

 Aristo Bio-Tech IPOChaman Metallics IPO
Financials

Company Financials (Restated)

Period Ended30 Sep 202231 Mar 202231 Mar 202131 Mar 2020
Assets108.6977.0081.4287.85
Total Income129.07166.03167.23201.24
Profit After Tax2.591.461.081.01
NET Worth17.4314.8413.3812.31
Reserves and Surplus12.449.858.397.31
Total Borrowing29.3625.4822.2519.71
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended30 Sep 202231 Mar 202231 Mar 202131 Mar 2020
Assets90.8673.7958.7253.99
Total Income111.82185.46140.7658.37
Profit After Tax6.829.355.233.69
NET Worth44.7338.0828.7323.50
Reserves and Surplus26.9730.1820.8415.61
Total Borrowing16.0825.1613.9319.76
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%100%
Promoter Shareholding (Post-Issue)73.37%73.6%
P/E Ratio9.466.73
Market Cap₹49.02 Cr.₹91.71 Cr.
ROE29.2624.54
ROCE35.6425.72
Debt/Equity5.100.66
EPS₹2.93₹5.26
RoNW1024.54

Shares Offered

In the Aristo Bio-Tech IPO Retail Individual Investors (RII) are offered 8,60,800 shares while in Chaman Metallics IPO retail investors are offered 8,60,800 shares. Qualified Institutional Buyers (QIB) are offered in Aristo Bio-Tech IPO and in Chaman Metallics IPO.

 Aristo Bio-Tech IPOChaman Metallics IPO
Market Maker Reservation91,200 shares3,24,000 shares
NII8,60,800 shares30,24,000 shares
RII8,60,800 shares30,24,000 shares
Total17,21,600 shares60,48,000 shares

Bids Received (Subscription)

Aristo Bio-Tech IPO subscribed 217.72x in total, whereas Chaman Metallics IPO subscribed 207.88x.

 Aristo Bio-Tech IPOChaman Metallics IPO
NII (times)285.84x255.92x
RII (times)149.59x159.85x
Total (times)217.72x207.88x

Compare with others

Compare: